cforms contact form by delicious:days
Care Credit Apply Now Promo PromoSalt Lake City Location
755 East 3900 South
Salt Lake City, UT 84107
800-760-4171
The Eye Institute of Utah performs all phases of Pharmaceutical and Medical Device clinical trials. We are unique in that we have surgical capabilities on site. It is a state-of-the-art facility that offers laser, retina-vitreous, glaucoma, cataract treatment and oculoplastic surgery. In both our clinical and ambulatory surgical centers, we treat all aspects of eye disease and anomalies, such as dry eye, ocular infections etc. Clinical studies at The Eye Institute of Utah are conducted to determine the safety and effectiveness of new devices, drugs, or procedures for the treatment of ocular disease.
The development of medical knowledge and technology requires and depends on research sites playing an active role in the investigation and testing of products coming to market.
We currently have four principal investigators on site with research experience varying from 5-35 years. Our principal investigators are trained on GCP’s as well as the FDA Code of Regulations. Since The Eye Institute of Utah was established in 1981 as the first and largest office-based eye surgical center in Utah, we are able to enroll the vast majority of our patients from our own patient population.
Our mission is to provide outstanding support to our community, sponsors and patients with the highest regard for patient safety and privacy. We are dedicated to excellence in the clinical research arena; we will provide the highest quality work with integrity and efficiency.
This study will look at the use of an investigational treatment for keratoconus known as corneal collagen cross-linking. Cross-linking uses riboflavin (vitamin B2) and a UV-A light source. It is designed to help improve or slow the progression of keratoconus and vision loss.
If you have keratoconus and would like to see if corneal collagen cross-linking is right for you, we have a consent process and a screening that needs to be performed in order to deterimine study eligibility.
We are testing the safety and efficacy of an investigational intraocular lens (IOL) that may correct for astigmatism and presbyopia. This lens is made of the same acrylic material that is used in other FDA approved intraocular lenses and have the same multifocal design, which means they provide both up close and distance vision. A mutlifocal lens has a greater potential to reduce dependency on glasses when compared with a monofocal lens.
If you’re interested in finding out if you qualify for this study, ask to speak with a study coordinator when contacting our office.
Have you been diagnosed with Dry Eye Syndrome, or do you experience any of the following chronic (long duration or frequent recurrence) symptoms?
If you answered yes, you may qualify to participate in a research study to evaluate the effects of an investigational product on dry eyes.
A formal consent process and ocular screening are required before decisions can be made about your enrollment and willingness to be involved with this study.
Compensation is available for your time and travel.
Do you need cataract surgery? If you answer yes, you may qualify to participate in a research study to evaluate the effects of an investigational ocular bandage.
A formal consent process and ocular screening are required before decisions can be made about your enrollment and willingness to be involved with this study.
Compensation is available for time and travel.
Do you have open-angle glaucoma? Are you currently using Xalatan to treat your glaucoma? If your answer is “yes” to both, then you may qualify for this study. To find out if you qualify, please contact our study coordinator. Compensation is available for your time and travel.
Do you or a family member have any of the following symptoms?
Acute (recent) symptoms, which may be in one or both eyes:
If you answered yes to any of these symptoms and they are a recent onset in the last three to five days, then you may qualify to participate in a research study to evaluate the effects of an investigational product on infection of the eye.
A formal consent process and ocular screening are required before decisions can be made about your enrollment and willingness to be involved with this study.
Compensation is available for time and travel.
If you are interested in any of the above studies and would like more information, call The Eye Institute at 800-760-4171. Please ask to speak with the Study Coordinator.